Optical power profiles and aberrations of a non-diffractive wavefront-shaping extended depth of focus intraocular lens

被引:1
作者
Garzon, Nuria [1 ]
Gomez-Pedrero, Jose Antonio [2 ]
Albarran-Diego, Cesar [3 ]
Fernandez-Nunez, Sara [2 ]
Villanueva Gomez-Chacon, Sara [1 ]
Garcia-Montero, Maria [1 ]
机构
[1] Univ Complutense Madrid, Dept Optometria & Vis, Av Arcos Jalon 118, Madrid 28037, Spain
[2] Univ Complutense Madrid, Dept Opt, Av Arcos Jalon 118, Madrid 28037, Spain
[3] Univ Valencia, Dept Opt & Optometria & Ciencias Vis, Doctor Moliner 50, Burjassot 46100, Valencia, Spain
关键词
IOL; EDoF; Power profile; Aberrometric profile; Optical quality; CLINICAL-OUTCOMES; QUALITY;
D O I
10.1007/s00417-024-06469-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose This study is to evaluate the optical characteristics of a non-diffractive wavefront-shaping intraocular lens which incorporates surface refractive modifications for shaping the wavefront in order to achieve extended depth of focus (EDoF) and to assess whether the nominal power of this IOL influences the attainable add power.Methods A commercially available optical bench NIMO TR1504 device (LAMBDA-X, Nivelles, Belgium) was employed to obtain full optical characterization of three non-diffractive EDoF intraocular lenses with + 10 D, + 20 D, and + 30 D powers. After NIMO measurements, data were computed using a custom-made MATLAB program (Mathworks, Inc., Natick, MA, USA) to evaluate the optical quality functions, such as the point spread function (PSF), wavefront profiles, and modulation transfer function (MTF) for two pupil sizes: 3 mm and 4.0 mm.Results The non-diffractive EDoF intraocular lens showed a central serrated power profile behavior with additions of + 2.00 to + 2.50 D over the nominal power. Higher order aberrations were found to be driven mainly by the spherical aberration, with almost null comatic influence. Optical quality metrics showed good values, better for a 3 mm pupil compared to a 4.5 mm one, as expected. The three IOL powers tested showed a very similar behavior in terms of power and aberrometric profiles, with minimal to null differences related to the nominal power.Conclusion The non-diffractive wavefront-shaping EDoF intraocular lens achieves a near addition up to + 2.50 D aiming for an extended range of vision, almost independently of the base power.
引用
收藏
页码:2897 / 2906
页数:10
相关论文
共 31 条
[1]  
AcrySof&TRADE, IQ VIVITY TRADE EXTE
[2]   Clinical Retinal Image Quality of a Non-diffractive Wavefront-Shaping Extended Depth of Focus (Vivity) Intraocular Lens [J].
Al-Amri, Saad Abdulrahman J. ;
Alio, Jorge L. ;
Milan-Castillo, Roberto ;
D'Oria, Francesco ;
Martinez-Abad, Antonio ;
Yebana, Pilar ;
Subirana, Nuria ;
Al-Harbi, Ziyad ;
Plaza-Puche, Ana B. ;
Alio del Barrio, Jorge L. .
JOURNAL OF REFRACTIVE SURGERY, 2023, 39 (02) :103-+
[3]  
Alcon FW TX, US PATENT LIST
[4]  
American National Standard for Ophthalmics, 2018, ANSI Z80.35-2018 extended depth of focus intraocular lenses
[5]   Optical Assessment and Expected Visual Quality of Four Extended Range of Vision Intraocular Lenses [J].
Azor, Juan Antonio ;
Vega, Fidel ;
Armengol, Jesus ;
Millan, Maria S. .
JOURNAL OF REFRACTIVE SURGERY, 2022, 38 (11) :688-+
[6]   Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL [J].
Bala, Chandra ;
Poyales, Francisco ;
Guarro, Merce ;
Ruiz Mesa, Ramon ;
Mearza, Ali ;
Varma, Devesh Kumar ;
Jasti, Srichand ;
Lemp-Hull, Jessie .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2022, 48 (02) :136-143
[7]   Optical Quality and Higher Order Aberrations of Refractive Extended Depth of Focus Intraocular Lenses [J].
Baur, Isabella D. ;
Yan, Weijia ;
Auffarth, Gerd U. ;
Khoramnia, Ramin ;
Labuz, Grzegorz .
JOURNAL OF REFRACTIVE SURGERY, 2023, 39 (10) :668-675
[8]   Visualization of Ray Propagation through Extended Depth-of-Focus Intraocular Lenses [J].
Baur, Isabella D. ;
Auffarth, Gerd U. ;
Yan, Weijia ;
Labuz, Grzegorz ;
Khoramnia, Ramin .
DIAGNOSTICS, 2022, 12 (11)
[9]  
Borkenstein Andreas F, 2021, Biomed Hub, V6, P77, DOI 10.1159/000519139
[10]  
clinicaltrials.gov, CLIN TRIALS